+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
540788 ASPIRA

Aspira Pathlab & Diagnostics Share Price

 

 

Aspira Pathlab & Diagnostics live price: ₹128.9. It opened at ₹129 vs previous close ₹132; intraday high/low: ₹129/₹129. The 50 & 200 DMA stand at ₹108.00/₹79.24.

Aspira Pathlab & Diagnostics Performance

  • Today's Low
  • ₹129
  • Today's High
  • ₹129
  • 52 Week Low
  • ₹49
  • 52 Week High
  • ₹136
  • Open Price₹129
  • Previous Close₹132
  • Volume637
  • 50 DMA₹108.00
  • 100 DMA₹91.92
  • 200 DMA₹79.24

Aspira Pathlab & Diagnostics Chart

Investment Returns

  • Over 1 Month + 0.66%
  • Over 3 Month + 121.97%
  • Over 6 Month + 102.8%
  • Over 1 Year + 131.34%

Smart Investing Starts Here Start SIP with Aspira Pathlab & Diagnostics for Steady Growth!

Invest Now

Aspira Pathlab & Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 2434.4
  • PEG Ratio
  • -25
  • Market Cap Cr
  • 133
  • P/B Ratio
  • 10.8
  • Average True Range
  • 3.12
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 7.56
  • RSI
  • 66.41
  • MFI
  • 68.29

Aspira Pathlab & Diagnostics Financials

Aspira Pathlab & Diagnostics Technicals

EMA & SMA

Current Price
₹128.90
-2.6 (-1.98%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹124.10
  • 50 Day
  • ₹108.00
  • 100 Day
  • ₹91.90
  • 200 Day
  • ₹79.20

Resistance and Support

128.9 Pivot Speed
  • R3 128.90
  • R2 128.90
  • R1 128.90
  • S1 128.90
  • S2 128.90
  • S3 128.90

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Aspira Pathlab & Diag has an operating revenue of Rs. 24.98 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 0% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 11%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 28% and 81% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 77% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 5 which is a POOR score indicating inconsistency in earnings, a RS Rating of 97 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 27 indicates it belongs to a strong industry group of Medical-Services and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Aspira Pathlab & Diagnostics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-23 Audited Results
2026-02-10 Quarterly Results
2025-11-12 Quarterly Results
2025-08-12 Quarterly Results
2025-05-16 Audited Results

Aspira Pathlab & Diagnostics Shareholding Pattern

18.39%
60.06%
21.55%

Aspira Pathlab & Diagnostics FAQs

Aspira Pathlab & Diagnostics share price is ₹128 As on 04 July, 2026 | 04:49

The Market Cap of Aspira Pathlab & Diagnostics is ₹132.7 Cr As on 04 July, 2026 | 04:49

The P/E ratio of Aspira Pathlab & Diagnostics is 2434.4 As on 04 July, 2026 | 04:49

The PB ratio of Aspira Pathlab & Diagnostics is 10.8 As on 04 July, 2026 | 04:49

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23